<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Jonatan Gabre | Ruth Palmer Lab</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/jonatan-gabre/</link><atom:link href="https://deploy-preview-3--ruthpalmerlab.netlify.app/author/jonatan-gabre/index.xml" rel="self" type="application/rss+xml"/><description>Jonatan Gabre</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><image><url>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/jonatan-gabre/avatar_hu67c13af330c5af2d5a32c5e81e954420_4509_270x270_fill_lanczos_center_3.png</url><title>Jonatan Gabre</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/author/jonatan-gabre/</link></image><item><title>Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/clean/</link><pubDate>Thu, 11 Jan 2024 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/clean/</guid><description/></item><item><title>ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/</link><pubDate>Tue, 02 Jan 2024 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/</guid><description/></item><item><title>ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/alkfusion_serpin/</link><pubDate>Tue, 21 Feb 2023 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/alkfusion_serpin/</guid><description/></item><item><title>Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/eml4_alk_rrm2/</link><pubDate>Thu, 01 Sep 2022 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/eml4_alk_rrm2/</guid><description/></item><item><title>ATR inhibition enables complete tumour regression in ALK-driven NB mouse models</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri1/</link><pubDate>Wed, 24 Nov 2021 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri1/</guid><description/></item><item><title>Loss of RET Promotes Mesenchymal Identity in Neuroblastoma Cells</title><link>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/loss_ret/</link><pubDate>Thu, 15 Apr 2021 00:00:00 +0000</pubDate><guid>https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/loss_ret/</guid><description/></item></channel></rss>